Epilepsy Clinical Trials
California Pacific Epilepsy Program Opens new window | Adult Clinical Trials Main Page
Further protocol information can be found on the links below at ClinicalTrials.gov
Active Trials
Title: A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures
Decscription: A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures
Investigator: David King-Stephens, MD
Eligibility: Subjects with a clinical diagnosis of primary generalized tonic-clonic seizures
Status: Active and open to enrollment
Contact: Douglas Raggett, RN, 415-600-3777,
Email: RaggettD@cpmcri.org about Study Eisai 332
Title: A Prospective, Open-label Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)
Description: A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)
Investigator: Kenneth Laxer, MD
Eligibility: Subjects with refractory complex partial seizures who are beginning treatment with Vigabatrin (Sabril®)
Status: Active and open to enrollment
Contact: Brian Macapinlac, 415-600-1627,
Email: MacapiB@cpmcri.org about Study Lundbeck
Title: A Historical-controlled, Multicenter, Double-blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400mg/Day Monotherapy in Subjects With Partial-onset Seizures
Decscription: Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures
Investigator: Kenneth Laxer, MD
Eligibility: Subjects with partial onset seizures
Status: Active and open to enrollment
Contact: Douglas Raggett, RN, 415-600-3777,
Email: RaggettD@cpmcri.org about Study UCB SP902
Title: A Multi-center, Open-label, Four-arm, Randomized Trial Evaluating the Safety and Tolerability of Brivaracetam Intravenous Infusion and Bolus, Administered in BID Regimen as an Adjunctive Antiepileptic Treatment in Subjects From 16 to 70 Years Suffering From Epilepsy
Decscription: Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy
Investigator: Kenneth Laxer, MD
Eligibility: Subjects with partial onset seizures
Status: Active and open to enrollment
Contact: Douglas Raggett, RN, 415-600-3777,
Email: RaggettD@cpmcri.org about Study UCB N01258
Title: A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥16 to 80 Years Old) With Partial Onset Seizures
Description: Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures
Investigator: David King-Stephens, MD
Eligibility: Subjects with partial onset seizures
Status: Active and open to enrollment
Contact: Douglas Raggett, RN, 415-600-3777,
Email: RaggettD@cpmcri.org about Study UCB N01358
Title: Responsive Neurostimulator (RNS™) System Long-term Treatment Clinical Investigation
Description: RNS™ System Long-term Treatment Clinical Investigation
Investigator: David King-Stephens, MD
Eligibility: For subjects who received the RNS™ system
Status: Active but not open to enrollment
Contact: Douglas Raggett, RN, 415-600-3777,
Email: RaggettD@cpmcri.org about Study NeuroPace LTT
- updated January 2012